References
- World Health Organization. WHO's pain ladder. Available at: www.who.int/cancer/palliative/painladder/en/index.html.
- Quigley C. The role of opioids in cancer pain. BMJ 2005;331: 825-829.
- Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007;61:1181-1187.
- Holzer P. Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs 2007;16:181-194.
- Nederlands Huisartsen Genootschap. Farmacotherapeutische Richtlijn Pijnbestrijding. Oktober 2007. Available at: nhg.artsennet.nl/upload/104/standaarden/FTR/Pijnbestrijding.html.
- van Schieveen S, Kramer P. Omgaan met obstipatie door sterke pijnmedicatie. Onderzoek onder patiënten en mantelzorgers. Available at: http://www.dubbelop.info/Portals/2/multimedia/TNSNIPOOmgaanmetoic.pdf.
- Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-380.
- Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005;7:R1046-1051.
- McMillan SC. Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control 2004;11:3-9.
- Cook SF, Lanza L, Zhou X, Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther 2008;27:1224-1232.
- Dennison C, Prasad M, Lloyd A, The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005;23:461-476.
- Wald A, Scarpignato C, Kamm MA, The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007;26:227-236.
- Bell TJ, Panchal SJ, Miaskowski C, The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med 2009;10:35-42.
- Slappendel R, Simpson K, Dubois D, Keininger DL. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain 2006;10: 209-217.
- Marquis P, De La Loge C, Dubois D, Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 2005;40:540-551.
- The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
- Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993;2:169-180.
- Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
- World Health Organization. Symptom relief in terminal illness. Geneva: World Health Organization, 1998;24-33.
- Fakata KL, Cole BE. Peripheral opioid antagonists: a therapeutic advance for optimizing opioid gastrointestinal tolerability. J Fam Pract 2007;56:S3-12.
- Moss J, Rosow CE. Development of peripheral opioid antagonists' new insights into opioid effects. Mayo Clin Proc 2008;83: 1116-1130.